136 related articles for article (PubMed ID: 18022818)
1. Molecular mechanisms of p21 and p27 induction by 3-methylcholanthrene, an aryl-hydrocarbon receptor agonist, involved in antiproliferation of human umbilical vascular endothelial cells.
Pang PH; Lin YH; Lee YH; Hou HH; Hsu SP; Juan SH
J Cell Physiol; 2008 Apr; 215(1):161-71. PubMed ID: 18022818
[TBL] [Abstract][Full Text] [Related]
2. RhoA-mediated inhibition of vascular endothelial cell mobility: positive feedback through reduced cytosolic p21 and p27.
Hsu YH; Chang CC; Yang NJ; Lee YH; Juan SH
J Cell Physiol; 2014 Oct; 229(10):1455-65. PubMed ID: 24535918
[TBL] [Abstract][Full Text] [Related]
3. Aryl hydrocarbon receptor mediates laminar fluid shear stress-induced CYP1A1 activation and cell cycle arrest in vascular endothelial cells.
Han Z; Miwa Y; Obikane H; Mitsumata M; Takahashi-Yanaga F; Morimoto S; Sasaguri T
Cardiovasc Res; 2008 Mar; 77(4):809-18. PubMed ID: 18065768
[TBL] [Abstract][Full Text] [Related]
4. Antiproliferative and antiangiogenic effects of 3-methylcholanthrene, an aryl-hydrocarbon receptor agonist, in human umbilical vascular endothelial cells.
Juan SH; Lee JL; Ho PY; Lee YH; Lee WS
Eur J Pharmacol; 2006 Jan; 530(1-2):1-8. PubMed ID: 16359657
[TBL] [Abstract][Full Text] [Related]
5. Aryl-hydrocarbon receptor-dependent alteration of FAK/RhoA in the inhibition of HUVEC motility by 3-methylcholanthrene.
Chang CC; Tsai SY; Lin H; Li HF; Lee YH; Chou Y; Jen CY; Juan SH
Cell Mol Life Sci; 2009 Oct; 66(19):3193-205. PubMed ID: 19649566
[TBL] [Abstract][Full Text] [Related]
6. 3-Methylcholanthrene, an AhR agonist, caused cell-cycle arrest by histone deacetylation through a RhoA-dependent recruitment of HDAC1 and pRb2 to E2F1 complex.
Chang CC; Sue YM; Yang NJ; Lee YH; Juan SH
PLoS One; 2014; 9(3):e92793. PubMed ID: 24658119
[TBL] [Abstract][Full Text] [Related]
7. Aryl hydrocarbon receptor-independent activation of estrogen receptor-dependent transcription by 3-methylcholanthrene.
Shipley JM; Waxman DJ
Toxicol Appl Pharmacol; 2006 Jun; 213(2):87-97. PubMed ID: 16257430
[TBL] [Abstract][Full Text] [Related]
8. 3-Methylcholanthrene and other aryl hydrocarbon receptor agonists directly activate estrogen receptor alpha.
Abdelrahim M; Ariazi E; Kim K; Khan S; Barhoumi R; Burghardt R; Liu S; Hill D; Finnell R; Wlodarczyk B; Jordan VC; Safe S
Cancer Res; 2006 Feb; 66(4):2459-67. PubMed ID: 16489053
[TBL] [Abstract][Full Text] [Related]
9. TSU-16, (Z)-3-[(2,4-dimethylpyrrol-5-yl)methylidenyl]-2-indolinone, is a potent activator of aryl hydrocarbon receptor and increases CYP1A1 and CYP1A2 expression in human hepatocytes.
Matsuoka-Kawano K; Yoshinari K; Nagayama S; Yamazoe Y
Chem Biol Interact; 2010 Apr; 185(1):33-41. PubMed ID: 20171196
[TBL] [Abstract][Full Text] [Related]
10. Mediating effects of aryl-hydrocarbon receptor and RhoA in altering brain vascular integrity: the therapeutic potential of statins.
Chang CC; Lee PS; Chou Y; Hwang LL; Juan SH
Am J Pathol; 2012 Jul; 181(1):211-21. PubMed ID: 22720799
[TBL] [Abstract][Full Text] [Related]
11. AHR and GPER mediate the stimulatory effects induced by 3-methylcholanthrene in breast cancer cells and cancer-associated fibroblasts (CAFs).
Cirillo F; Lappano R; Bruno L; Rizzuti B; Grande F; Guzzi R; Briguori S; Miglietta AM; Nakajima M; Di Martino MT; Maggiolini M
J Exp Clin Cancer Res; 2019 Aug; 38(1):335. PubMed ID: 31370872
[TBL] [Abstract][Full Text] [Related]
12. Activation of the aryl hydrocarbon receptor induces hepatic steatosis via the upregulation of fatty acid transport.
Kawano Y; Nishiumi S; Tanaka S; Nobutani K; Miki A; Yano Y; Seo Y; Kutsumi H; Ashida H; Azuma T; Yoshida M
Arch Biochem Biophys; 2010 Dec; 504(2):221-7. PubMed ID: 20831858
[TBL] [Abstract][Full Text] [Related]
13. Ah receptor-mediated suppression of liver regeneration through NC-XRE-driven p21Cip1 expression.
Jackson DP; Li H; Mitchell KA; Joshi AD; Elferink CJ
Mol Pharmacol; 2014 Apr; 85(4):533-41. PubMed ID: 24431146
[TBL] [Abstract][Full Text] [Related]
14. p27-Associated G1 arrest induced by hinokitiol in human malignant melanoma cells is mediated via down-regulation of pRb, Skp2 ubiquitin ligase, and impairment of Cdk2 function.
Liu S; Yamauchi H
Cancer Lett; 2009 Dec; 286(2):240-9. PubMed ID: 19631451
[TBL] [Abstract][Full Text] [Related]
15. PPARdelta-mediated p21/p27 induction via increased CREB-binding protein nuclear translocation in beraprost-induced antiproliferation of murine aortic smooth muscle cells.
Sue YM; Chung CP; Lin H; Chou Y; Jen CY; Li HF; Chang CC; Juan SH
Am J Physiol Cell Physiol; 2009 Aug; 297(2):C321-9. PubMed ID: 19587222
[TBL] [Abstract][Full Text] [Related]
16. Modulation of vascular smooth muscle cell growth by magnesium-role of mitogen-activated protein kinases.
Touyz RM; Yao G
J Cell Physiol; 2003 Dec; 197(3):326-35. PubMed ID: 14566962
[TBL] [Abstract][Full Text] [Related]
17. Vorinostat enhances protein stability of p27 and p21 through negative regulation of Skp2 and Cks1 in human breast cancer cells.
Uehara N; Yoshizawa K; Tsubura A
Oncol Rep; 2012 Jul; 28(1):105-10. PubMed ID: 22484732
[TBL] [Abstract][Full Text] [Related]
18. Focal adhesion kinase controls cellular levels of p27/Kip1 and p21/Cip1 through Skp2-dependent and -independent mechanisms.
Bryant P; Zheng Q; Pumiglia K
Mol Cell Biol; 2006 Jun; 26(11):4201-13. PubMed ID: 16705171
[TBL] [Abstract][Full Text] [Related]
19. Aryl hydrocarbon receptor-dependent regulation of miR-196a expression controls lung fibroblast apoptosis but not proliferation.
Hecht E; Zago M; Sarill M; Rico de Souza A; Gomez A; Matthews J; Hamid Q; Eidelman DH; Baglole CJ
Toxicol Appl Pharmacol; 2014 Nov; 280(3):511-25. PubMed ID: 25178717
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms involved in resveratrol-induced apoptosis and cell cycle arrest in prostate cancer-derived cell lines.
Benitez DA; Pozo-Guisado E; Alvarez-Barrientos A; Fernandez-Salguero PM; Castellón EA
J Androl; 2007; 28(2):282-93. PubMed ID: 17050787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
